Compounds > fosamprenavir
Page last updated: 2024-09-03

fosamprenavir and Chronic Hepatitis C

fosamprenavir has been researched along with Chronic Hepatitis C in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Degli Antoni, A; Ferrari, C; Fragola, V; Manfredi, R; Weimer, LE1
Corsini, F; Lanzafame, M; Lattuada, E1
Atripaldi, L; D'Antonio, A; Perrella, A; Perrella, O; Sbreglia, C1

Other Studies

4 other study(ies) available for fosamprenavir and Chronic Hepatitis C

ArticleYear
A reduced grade of liver fibro-steatosis after raltegravir, maraviroc and fosamprenavir in an HIV/HCV co-infected patient with chronic hepatitis, cardiomyopathy, intolerance to nelfinavir and a marked increase of serum creatine phosphokinase levels probab
    The West Indian medical journal, 2012, Volume: 61, Issue:9

    Topics: Adult; Carbamates; Cardiomyopathies; Chemical and Drug Induced Liver Injury; Creatine Kinase; Cyclohexanes; Drug Substitution; Drug Therapy, Combination; Fatty Liver; Furans; Hepatitis C, Chronic; HIV Fusion Inhibitors; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; Humans; Liver Cirrhosis; Male; Maraviroc; Organophosphates; Pyrrolidinones; Raltegravir Potassium; Sulfonamides; Triazoles

2012
[Individualized therapy with fosamprenavir/r. A PI suitable in liver problems].
    MMW Fortschritte der Medizin, 2008, Apr-28, Volume: 150 Spec No 1

    Topics: Anti-HIV Agents; Carbamates; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Furans; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infections; HIV Protease Inhibitors; Humans; Liver Function Tests; Organophosphates; Ritonavir; Sulfonamides; Viral Load

2008
Comment on: Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:1

    Topics: Anti-HIV Agents; Carbamates; Furans; Hepatitis C, Chronic; HIV Infections; Humans; Liver Cirrhosis; Organophosphates; Sulfonamides

2009
Fosamprenavir treatment in a highly active antiretroviral therapy schedule induces a HCV-RNA decrease and a Th1 network boost in HIV/HCV-coinfected patients.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:6

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Carbamates; CD4 Lymphocyte Count; Female; Furans; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-gamma; Interleukin-4; Male; Organophosphates; RNA, Viral; Sulfonamides; Transaminases; Viral Load

2010